These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 35441574)
1. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression. Li D; Fu Z; Dong C; Song Y Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574 [TBL] [Abstract][Full Text] [Related]
2. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1. Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761 [TBL] [Abstract][Full Text] [Related]
3. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer. Liu C; Ren Q; Deng J; Wang S; Ren L Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794 [TBL] [Abstract][Full Text] [Related]
4. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p. Qi L; Yin Y; Sun M Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification. Fan Y; Yu Y Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505 [TBL] [Abstract][Full Text] [Related]
6. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way. Dou X; Wang Z; Lu W; Miao L; Zhao Y BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805 [TBL] [Abstract][Full Text] [Related]
7. m Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312 [TBL] [Abstract][Full Text] [Related]
8. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of Lung Cancer]. Zhang Y; Wang Y; Liu M Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978 [TBL] [Abstract][Full Text] [Related]
9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of m6A regulators prognostic value in prostate cancer. Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725 [TBL] [Abstract][Full Text] [Related]
11. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC. Cao Y; Di X; Cong S; Tian C; Wang Y; Jin X; Zhao M; Zhou X; Li R; Wang K Life Sci; 2023 Feb; 315():121359. PubMed ID: 36608868 [TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19. Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240 [TBL] [Abstract][Full Text] [Related]
13. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma. Wang W; Li S Recent Pat Anticancer Drug Discov; 2024; 19(5):652-665. PubMed ID: 37877146 [TBL] [Abstract][Full Text] [Related]
15. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function. Du Y; Hou G; Zhang H; Dou J; He J; Guo Y; Li L; Chen R; Wang Y; Deng R; Huang J; Jiang B; Xu M; Cheng J; Chen GQ; Zhao X; Yu J Nucleic Acids Res; 2018 Jun; 46(10):5195-5208. PubMed ID: 29506078 [TBL] [Abstract][Full Text] [Related]
16. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma. Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834 [No Abstract] [Full Text] [Related]
17. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression. Zhang Y; Liu S; Zhao T; Dang C Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367 [TBL] [Abstract][Full Text] [Related]
18. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression. Li S; Lu X; Zheng D; Chen W; Li Y; Li F J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010 [TBL] [Abstract][Full Text] [Related]
19. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression. He G; Gu K; Wei J; Zhang J Thorac Cancer; 2024 Apr; 15(11):919-928. PubMed ID: 38462740 [TBL] [Abstract][Full Text] [Related]
20. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1. Miao W; Chen J; Jia L; Ma J; Song D Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]